Vitamin A Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Vitamin A dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Vitamin A.
Dosing Protocols
Beginner protocol (general health; dietary adequacy). For healthy adults eating a varied diet: no supplementation required. Aim for dietary RDA of 900 μg RAE for men and 700 μg RAE for women from a combination of animal sources (eggs, dairy, oily fish, occasional liver) and plant sources (orange and dark green vegetables for β-carotene). A serving of beef liver (100 g) supplies roughly 6-9 mg retinol equivalents — above the weekly intake recommended by some nutritionists — so organ meat once or twice a month is more than adequate. Two large eggs provide about 300 μg RAE; one cup cooked sweet potato provides about 1,400 μg RAE as β-carotene (real retinol equivalent lower due to conversion inefficiency). A standard multivitamin providing 3,000-5,000 IU retinol + 5,000-10,000 IU β-carotene is acceptable but not necessary.
For populations at risk of deficiency (severe malabsorption, cystic fibrosis, cholestatic liver disease, post-bariatric surgery): follow specialist-guided supplementation, typically 5,000-10,000 IU/day preformed retinyl ester in water-soluble formulation, with periodic monitoring of serum retinol, RBP4, and liver function.
For infants and young children in low-resource settings with endemic deficiency: WHO protocols of 100,000 IU (6-11 months) or 200,000 IU (12-59 months) every 4-6 months are the global standard. Outside these contexts, pediatric supplementation follows standard multivitamin dosing.
Topical routine (beginner). For mild photoaging prevention or uncomplicated comedonal acne: over-the-counter adapalene 0.1% gel once nightly, starting 2-3 times per week and titrating to nightly over 4-6 weeks. Pair with broad-spectrum SPF 30+ during the day. Expect mild flaking and erythema during initiation; resolves with continued use and moisturizer.
Intermediate protocol (dermatology and moderate indications). For moderate inflammatory acne: tretinoin 0.025-0.05% cream or gel nightly (ramping up over 4-6 weeks from 2-3 times per week), combined with benzoyl peroxide 2.5-5% gel in the morning or clindamycin 1% solution in the morning. For photoaging in adults aged 30+: tretinoin 0.025-0.05% nightly, build tolerance over 8-12 weeks, with an evidence-based expectation of reduced fine wrinkles, improved mottled hyperpigmentation, and improved tactile roughness at 24-48 weeks. Broad-spectrum SPF 30+ daily is mandatory.
For patients in countries where alitretinoin is approved and severe chronic hand eczema is refractory to potent topical corticosteroids: alitretinoin 30 mg/day for 12-24 weeks per specialist prescribing. Expect improvement at weeks 8-12; stop if no response by week 24.
For adults with documented marginal vitamin A status (low serum retinol, low-normal RBP4) due to poor dietary intake, modest fat malabsorption, or chronic alcohol use: supplementation with 5,000 IU preformed retinol (as retinyl palmitate or acetate) daily for 4-8 weeks, then reassess. Retest serum retinol and RBP4. Do not continue indefinitely at this dose without ongoing rationale.
For women planning pregnancy: ensure preformed vitamin A intake stays at or below the RDA of 700 μg RAE and below 2,500-3,000 IU/day to minimize teratogenic risk; β-carotene in reasonable quantities is safe. A standard prenatal vitamin providing 4,000 IU (some include this as β-carotene, which is preferable) is appropriate; avoid adding a separate vitamin A supplement.
For smokers — explicit contraindication: do not supplement with β-carotene at doses above dietary intake. Avoid β-carotene supplements entirely. Food-source β-carotene is safe.
Advanced protocol (prescription-tier and specialty indications). Oral isotretinoin for severe nodulocystic acne: 0.5-1.0 mg/kg/day (start 0.5 mg/kg/day, increase to 1 mg/kg/day as tolerated) for 16-24 weeks, targeting cumulative dose of 120-150 mg/kg. Standard monitoring includes baseline and monthly LFTs, fasting lipid panel, CBC, and for women of childbearing potential, monthly pregnancy testing per iPLEDGE with dual contraception for one month prior, throughout treatment, and one month after completion. Expect xerosis, cheilitis, myalgia, and triglyceride elevation; manage with emollients, lip balm, hydration, and in rare cases dose reduction. Approximately 70-80% of patients achieve durable remission after a single course; approximately 20-30% require a second 16-20 week course. Stop-rules: transaminases >3× upper limit of normal, triglycerides >500 mg/dL, signs of IBD flare, pseudotumor cerebri, unexplained mood changes.
Acitretin for severe psoriasis: 25-50 mg/day per dermatology prescribing. Significant teratogenic risk extends 3 years after discontinuation due to reverse metabolism to etretinate; absolute contraindication in women of childbearing potential unless permanent contraception acceptable. Monitor LFTs, lipids, and skeletal radiographs for hyperostosis with chronic dosing.
Bexarotene for relapsed/refractory cutaneous T-cell lymphoma: 300 mg/m²/day orally. Oncology specialty. Expect central hypothyroidism (requires TSH-independent levothyroxine titration), severe hypertriglyceridemia (requires fenofibrate concurrent therapy, not gemfibrozil which elevates bexarotene levels), and characteristic retinoid adverse effect profile.
ATRA for acute promyelocytic leukemia: 45 mg/m²/day oral in two divided doses as part of combined induction and consolidation regimens (typically with arsenic trioxide for low-to-intermediate risk, with anthracycline for high-risk disease). Hematology specialty. Premedicate with dexamethasone 10 mg IV twice daily for first 3-5 days to reduce differentiation syndrome risk; continue ATRA through syndrome events with dexamethasone management. Consolidation and maintenance per cooperative group protocols (GIMEMA/AIDA, MRC, US Intergroup, APL0406).
Long-standing daily vitamin A supplementation in adults without a specific clinical indication — discouraged. If a patient is chronically taking preformed vitamin A above 10,000 IU/day for years, consider dose reduction, switch to mixed carotenoids, and retinol-screening. Chronic hypervitaminosis A is reversible in early stages but hepatic fibrosis may be persistent.
Stop rules (all vitamin A contexts): acute vision change or papilledema (pseudotumor cerebri work-up), new unexplained headache with vomiting, acute hepatic enzyme elevation >3× ULN, significant bone or joint pain, suspected pregnancy on any oral retinoid therapy (stop immediately and engage reproductive counseling).
Commonly Stacked With
Vitamin A stacks strategically with its fat-soluble cousins, with nutrients that support its transport and activation biology, and with specific therapeutic contexts. Thoughtful stacking amplifies benefit; reflexive stacking amplifies risk.
Fat-soluble vitamin core. Vitamin A, vitamin D3, vitamin E (α-tocopherol), and vitamin K2 (MK-7 or MK-4) form a functionally coupled set. A/D share RXR as heterodimer partner, meaning retinoid status modulates vitamin D signaling; K2 activates osteocalcin and MGP that handle calcium deposition that D promotes absorption of; vitamin E protects retinoid and other polyunsaturated lipids from oxidation. An "ADEK" supplement is standard in cystic fibrosis and chronic cholestatic malabsorption. For the healthy adult, an ADEK complex at modest doses (retinol 1,500-3,000 IU, D3 2,000-4,000 IU, K2-MK7 100-180 μg, vitamin E 15-30 mg natural mixed tocopherols) is a reasonable fat-soluble chassis, though food sources (fatty fish, egg yolks, liver occasionally, dairy, leafy greens, nuts) can supply most of this.
Zinc and retinol binding protein. Zinc is required for RBP4 synthesis in hepatocytes; zinc deficiency causes functional retinol deficiency even with adequate liver stores because RBP cannot be secreted. For patients with mixed deficiency (as in many low-resource settings), combined zinc 15-30 mg + vitamin A supplementation corrects both deficiencies and optimizes retinol delivery to tissue. Gabr 2013and others have shown additive benefit in pediatric populations. Routine co-supplementation in healthy adults is not necessary.
Iron and vitamin A interaction. Vitamin A supports erythropoiesis via RAR-mediated regulation of iron metabolism genes. Vitamin A deficiency produces a functional iron-deficient anemia that does not respond to iron alone. In malnourished populations, combined iron + vitamin A repletion outperforms either alone (Suharno 1993 Lancet). For healthy adults with isolated iron deficiency, iron supplementation alone is standard; for populations with mixed micronutrient deficiency, combined approach is better.
Retinoid + alpha-lipoic acid + vitamin E antioxidant cushion. In topical and oral retinoid therapy, oxidative stress in treated tissues is a side effect mechanism. Combining oral vitamin E 15-30 mg natural mixed tocopherols and α-lipoic acid 300-600 mg/day may soften retinoid irritation and hepatic stress, though controlled evidence for the benefit is modest. Reasonable for patients on isotretinoin long-term therapy.
Avoid vitamin A + preformed retinol on top of systemic retinoid drugs. Isotretinoin, acitretin, bexarotene, or alitretinoin therapy should not be combined with supplemental vitamin A above the RDA, as effects are additive and risk of hypervitaminosis A increases. If a patient on isotretinoin takes a multivitamin, confirm total preformed vitamin A stays below 2,500-5,000 IU/day.
β-Carotene + vitamin E — careful stacking. Natural carotenoids and tocopherols work together in lipid bilayers; a mixed-carotenoid and mixed-tocopherol supplement is more physiologically appropriate than isolated β-carotene + α-tocopherol. However, as ATBC and CARET demonstrated, high-dose β-carotene (especially as isolated supplement) is contraindicated in smokers. A reasonable stack in non-smokers: mixed carotenoids 3-6 mg (including β-carotene, α-carotene, lutein, lycopene) + mixed natural tocopherols 15-30 mg, ideally from a whole-food concentrate rather than isolated synthetic forms.
Topical tretinoin + hyaluronic acid + niacinamide. For acne and photoaging, tretinoin 0.025-0.05% at night, alternating or layered with a hyaluronic acid serum for hydration and niacinamide 5% serum for barrier support, is a well-tolerated synergistic routine. Niacinamide modulates inflammation and reduces tretinoin-associated erythema. Morning routine: gentle cleanser, moisturizer, broad-spectrum SPF 30+.
Topical tretinoin + benzoyl peroxide for acne. Evidence-based pairing for mild-to-moderate inflammatory acne. Use BPO morning, tretinoin evening to minimize tretinoin oxidation (old tretinoin formulations were degraded by concurrent BPO; newer microencapsulated tretinoin like Altreno has solved this, and combination products Veltin and Ziana exist). Clindamycin or erythromycin adds antimicrobial coverage but should be time-limited to prevent resistance.
Oral isotretinoin + appropriate contraception. Non-negotiable dual contraception during and one month after isotretinoin therapy per iPLEDGE. Not a "stack" in the supplement sense, but worth explicit mention because oral contraceptives alone are not considered adequate, and barrier + hormonal or barrier + IUD combinations are required.
Acne nutritional stack (low-evidence but low-risk). Some dermatologists recommend zinc 30-50 mg/day, omega-3 fatty acids 1-2 g EPA+DHA/day, and vitamin D3 2,000-4,000 IU/day as adjuncts to standard acne therapy. Vitamin A at normal dietary intake fits in this frame; do not stack megadose retinyl esters on top of isotretinoin.
Cold and upper respiratory illness. Vitamin A modulates mucosal immunity, and in vitamin-A-deficient populations, supplementation reduces infection severity. In non-deficient populations, routine vitamin A supplementation during cold season has not been shown to prevent or shorten URIs. Focus on zinc lozenges in the first 24 hours of symptoms, vitamin C 1-2 g/day, and rest, rather than high-dose vitamin A.
APL treatment stack. ATRA + arsenic trioxide for low-to-intermediate risk; ATRA + anthracycline chemotherapy (idarubicin) for high-risk (WBC >10,000). Prophylactic dexamethasone is often used to mitigate differentiation syndrome. This is oncology specialty care and not a supplement stack.
Avoid stacking vitamin A with tetracyclines. Minocycline, doxycycline, and tetracycline combined with vitamin A supplementation or oral retinoids (isotretinoin) increase pseudotumor cerebri risk. This is particularly relevant for acne patients who may be on both minocycline and isotretinoin — dermatology practice typically does not overlap these.
Avoid megadose vitamin A in patients on vitamin D or vitamin K at higher doses. Nuclear receptor crosstalk (RXR competition) means chronic high-dose vitamin A can blunt vitamin D-mediated calcium absorption and osteocalcin carboxylation — suboptimal when bone health is a goal. Keep preformed vitamin A at or below the RDA when stacking with D3 and K2.
Liver support during chronic retinoid use. For patients on long-term isotretinoin or acitretin, consider milk thistle silymarin 140 mg twice daily or n-acetylcysteine 600-1200 mg/day as hepatic support. Evidence for clinical benefit is limited but mechanism is plausible and risk is minimal. Monitor LFTs per standard protocol regardless of supplementation.
Side Effects & Safety
Contraindications
Vitamin A has several absolute contraindications at supplementation doses and additional precautions for therapeutic retinoid drugs. Context and dose matter substantially. Absolute contraindications: - Pregnancy and attempted conception: avoid preformed vitamin A supplementation above the RDA (>2,500-3,000 IU/day); avoid all oral retinoid drugs (isotretinoin, acitretin, bexarotene, alitretinoin) per category X teratogen classifications. β-Carotene is not teratogenic and is acceptable during pregnancy. Retinol intake above 10,000 IU/day in early pregnancy has been associated with increased risk of neural crest-derived malformations (Rothman 1995). - Active breastfeeding: avoid oral retinoid drugs; retinol supplementation at or near RDA (1,200-1,300 μg RAE for lactation) is appropriate. - Current or recent tobacco use: avoid β-carotene supplementation above dietary intake due to increased lung cancer and total mortality (ATBC PMID 8127329; CARET PMID 8602180). Preformed vitamin A at physiologic intake is safe. - Known hypersensitivity to vitamin A, retinoid drugs, or excipients (parabens, sodium bisulfite in some injectables, polysorbate). - Active pseudotumor cerebri: vitamin A supplementation or retinoid therapy is contraindicated until resolved. - Severe hepatic impairment: relative contraindication to high-dose preformed vitamin A supplementation due to compromised storage and metabolism; specialist guidance required. Relative precautions: - Postmenopausal women and older adults with osteoporosis or fracture risk factors: avoid chronic preformed vitamin A intake above 3,000 μg/day due to fracture signal (Feskanich 2002; Michaelsson 2003). β-Carotene is acceptable. - Current tetracycline or doxycycline or minocycline therapy: avoid concurrent high-dose vitamin A or oral retinoid drugs due to additive pseudotumor cerebri risk. - Warfarin or other anticoagulant therapy: monitor INR with any change in vitamin A supplementation; theoretical but rarely clinically significant at typical doses. - Hyperlipidemia, particularly hypertriglyceridemia: retinoid drugs commonly raise triglycerides; screen baseline fasting lipids and monitor during therapy. - Chronic heavy alcohol use: potentiates hepatic retinol storage and toxicity; limit preformed vitamin A intake and avoid oral retinoid drugs. - Current [vitamin A](/compound/vitamin-a) or oral retinoid therapy: do not stack supplemental preformed vitamin A on top of prescription retinoid drug without dermatology or oncology guidance. - Inflammatory bowel disease (historical concern with isotretinoin): rigorous pharmacoepidemiology (Alhusayen 2013 and subsequent) does not support causation, but patients with active IBD should avoid oral retinoid drugs until discussed with both gastroenterology and dermatology. - History of depression or suicidality: the isotretinoin-depression association is controversial; meta-analyses do not find increased depression risk vs. comparable acne severity (Huang 2017), but monitoring is warranted, and patients with active untreated depression or recent suicidal ideation should be optimized psychiatrically before starting isotretinoin. - Hearing loss of unclear etiology: rare reports of retinoid-associated hearing changes; weigh risk-benefit. - Scheduled elective surgery: some surgeons recommend discontinuing isotretinoin 6 months prior to procedures (laser resurfacing, chemical peels, dermabrasion) due to concerns about delayed wound healing, though this practice is evolving; consult operative surgeon. Drug-drug interactions: - Tetracyclines + vitamin A / retinoids: avoid concurrent high-dose (pseudotumor cerebri risk). - Other oral retinoids + supplemental vitamin A: avoid (additive hypervitaminosis risk). - Methotrexate + acitretin: avoid concurrent (increased hepatotoxicity). - Bile acid sequestrants (cholestyramine, colestipol) + vitamin A: reduced absorption; space by 4 hours. - Orlistat + vitamin A: reduced absorption; space by 2 hours, monitor status in long-term orlistat therapy. - Anticonvulsants (phenytoin, carbamazepine, phenobarbital) + vitamin A: induction of retinol metabolism; may require higher doses. - Warfarin + high-dose vitamin A: theoretical INR effects. - Alcohol + high-dose vitamin A: hepatotoxicity. Supplement-supplement considerations: - [Vitamin D3](/compound/vitamin-d3) + high-dose vitamin A: potential RXR competition reducing vitamin D efficacy; keep vitamin A at or below RDA when D3 is being used for documented deficiency or bone health. - [Vitamin K2](/compound/vitamin-k2) + vitamin A: compatible at normal doses; no documented interaction. - [Iron](/compound/iron) + vitamin A: synergistic for erythropoiesis in mixed deficiency; no concerning interaction. - [Zinc](/compound/zinc) + vitamin A: synergistic for RBP4 synthesis; recommended co-supplementation in deficient populations. - Fish oil + vitamin A (as cod liver oil): 1 teaspoon cod liver oil typically provides 1,500-4,000 IU vitamin A — factor into total daily intake when assessing UL. Pediatric contraindications. Isotretinoin, acitretin, bexarotene, and alitretinoin are not first-line in pediatric populations; pediatric use requires careful specialist consideration. WHO pediatric deficiency supplementation protocols (100,000-200,000 IU every 4-6 months) are safe in context but inappropriate outside deficiency settings. Surgical and procedural considerations. Some surgeons require discontinuation of isotretinoin 6 months before certain cosmetic procedures (laser, dermabrasion, chemical peel) due to concern about impaired wound healing, although contemporary literature suggests this restriction may be overly conservative. Consult the operative surgeon. The consistent theme: vitamin A supports essential biology but has a narrower therapeutic window than the B-complex or most water-soluble vitamins. Respect the dose-response, respect pregnancy, respect tobacco history, and prefer food sources whenever possible.
Additional Notes
Vitamin A dosing requires attention to form (preformed retinol vs. β-carotene vs. therapeutic retinoid), unit conventions (IU vs. μg RAE), age, sex, pregnancy status, and indication. Sloppy unit conversion is a common source of dosing errors in this family.
Unit conventions. 1 IU vitamin A = 0.3 μg retinol = 0.3 μg RAE (retinol activity equivalent) = 0.6 μg β-carotene in supplement form (1:2 ratio for supplement β-carotene → retinol) = 3.6 μg β-carotene from food (1:12 for food β-carotene → retinol, per the 2001 Institute of Medicine revision accounting for carotenoid conversion inefficiency). 1 μg RAE = 3.33 IU vitamin A. These conversions matter because supplement labels frequently report IU while dietary recommendations are in μg RAE — and they are not interchangeable numbers.
RDA and AI. Adults 19+: 900 μg RAE/day (3,000 IU) for men, 700 μg RAE/day (2,333 IU) for women. Pregnancy: 750 μg RAE (14-18 years), 770 μg RAE (19+). Lactation: 1,200 μg RAE (14-18 years), 1,300 μg RAE (19+). Infants (AI): 400 μg RAE (0-6 months), 500 μg RAE (7-12 months). Children: 300 μg (1-3 years), 400 μg (4-8 years), 600 μg (9-13 years). Adolescents 14-18: 900 μg (male), 700 μg (female).
Tolerable upper intake level (preformed vitamin A only; β-carotene does not have an established UL from food but high supplement doses are not recommended): adults 3,000 μg RAE (10,000 IU) per day for chronic daily consumption. This is the threshold above which chronic hepatotoxicity, bone density concerns, and (in pregnancy) teratogenicity become clinically meaningful.
Typical supplementation doses by indication. Multivitamin insurance: 2,500-5,000 IU/day mixed retinol + β-carotene, often split 40/60 or 50/50. Cystic fibrosis and malabsorption replacement: 5,000-10,000 IU/day preformed retinol in water-soluble formulation, or up to 15,000-25,000 IU/day initially with titration based on serum retinol and RBP4 — specialist-guided. WHO pediatric deficiency protocols: 100,000 IU at 6-11 months, 200,000 IU at 12-59 months, repeated every 4-6 months. Xerophthalmia treatment (WHO): 200,000 IU oral on days 1, 2, and 14 for children >12 months (reduce for infants).
Therapeutic retinoid dosing. Oral isotretinoin: 0.5-1 mg/kg/day divided BID with fatty meal for 16-24 weeks, cumulative dose 120-150 mg/kg. Acitretin: 25-50 mg/day. Alitretinoin: 30 mg/day. Bexarotene: 300 mg/m²/day (oncology). ATRA (tretinoin, for APL): 45 mg/m²/day divided BID. Topical tretinoin: 0.025-0.1% once daily at bedtime. Topical adapalene: 0.1-0.3% once daily. Topical tazarotene: 0.05-0.1% once daily.
Bioavailability. Preformed retinyl esters: 70-90% absorbed with adequate dietary fat. Retinol in water-soluble (polysorbate-solubilized) preparations: higher absorption in fat-malabsorption settings. β-Carotene from supplement oil: 10-25% absorbed, then 2:1 retinol conversion at best, often less depending on BCO1 genotype. β-Carotene from raw vegetables: poor absorption (5-10%) due to cellular matrix; cooking in oil and mechanical disruption (blending) substantially improves. BCO1 rs7501331 T170M and rs12934922 A379V carriers convert β-carotene 30-70% less efficiently than wild-type (Leung 2009).
Timing. Take preformed retinol or β-carotene supplements with the largest fat-containing meal of the day to maximize absorption. Oral isotretinoin should be taken with a fatty meal (or Absorica/Absorica LD newer formulations that are less fat-dependent). Topical tretinoin nightly, on dry skin, 20 minutes after cleansing.
Interactions. Orlistat reduces fat-soluble vitamin absorption; space by at least 2 hours. Cholestyramine and colestipol similarly reduce absorption. Mineral oil (laxative) reduces absorption. Anti-epileptic drugs (phenytoin, carbamazepine, phenobarbital) induce retinol metabolism; higher doses may be needed. Tetracyclines increase pseudotumor cerebri risk with vitamin A or retinoids; avoid concurrent high-dose. Warfarin INR may rise with high vitamin A; monitor.
Special populations. Pregnancy: keep preformed retinol at or below RDA; avoid doses >10,000 IU; β-carotene is safe. Lactation: RDA can be liberal. Pediatric: use weight-appropriate dosing; megadose WHO protocols are safe in deficiency contexts but inappropriate in non-deficient populations. Elderly: do not stand-alone supplement with preformed retinol >3,000 μg/day due to fracture risk signal. Fat malabsorption (CF, cholestatic disease, short bowel, bariatric surgery): use water-soluble formulations, dose-titrate to serum retinol and RBP4 targets. Hepatic disease: interpret serum retinol cautiously as RBP4 synthesis falls with hepatic dysfunction; liver stores may still be adequate or excessive.
Monitoring for high-dose supplementation. Serum retinol, retinyl ester (elevated retinyl esters indicate over-supplementation even when retinol is normal), RBP4, liver enzymes, and bone density for chronic dosing. Fasting lipids for oral retinoid drugs.
Frequently Asked Questions
What is the recommended Vitamin A dosage?
Dosage for Vitamin A varies by protocol. Consult a qualified healthcare provider.
How often should I take Vitamin A?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Vitamin A need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Vitamin A side effects?
Vitamin A has a narrower therapeutic index than most vitamins, and hypervitaminosis A is clinically relevant. Safety considerations vary dramatically by form (preformed retinol, β-carotene, topical retinoid, oral retinoid drug), dose, and duration. Acute hypervitaminosis A. Ingestion of very large single doses (>500,000-1,000,000 IU in adults, less in children) produces nausea, vomiting, vertigo, headache, blurred vision, and skin desquamation within hours to days. Classic sources include polar bear, seal, or certain fish livers (Arctic explorer cases), industrial accidents, and medication errors with concentrated fish liver oils. Symptoms typically resolve within days to weeks of cessation. Acute intracranial hypertension ("pseudotumor cerebri") with papilledema can occur and requires ophthalmologic and neurology evaluation. Chronic hypervitaminosis A. Daily intake of preformed vitamin A above 10,000 IU (3,000 μg) for months to years is associated with: dry skin and cheilitis, alopecia, fatigue and malaise, anorexia and weight loss, bone and joint pain, hepatomegaly and elevated transaminases, possible hepatic fibrosis with chronic very-high-dose exposure, pseudotumor cerebri with chronic headache and visual symptoms, and in observational studies, increased fracture risk (Melhus 1998; Michaelsson 2003). The Institute of Medicine's tolerable upper intake level for preformed vitamin A in adults is 3,000 μg RAE (10,000 IU) per day for chronic daily consumption. Teratogenicity. Vitamin A in doses exceeding 10,000 IU/day during pregnancy has been associated with increased risk of birth defects in observational studies (Rothman 1995 reported increased neural crest-derived malformations above 10,000 IU/day). Isotretinoin is an FDA category X teratogen with approximately 25% major malformation rate in first-trimester-exposed pregnancies (Lammer 1985 NEJM), producing characteristic retinoic acid embryopathy: craniofacial dysmorphism (microtia, anotia, micrognathia), cardiac malformations (conotruncal defects), CNS anomalies (hydrocephalus, microcephaly, cerebellar hypoplasia), and thymic abnormalities. The FDA iPLEDGE program mandates monthly pregnancy testing and dual contraception for isotretinoin-treated women of childbearing potential. Acitretin and bexarotene have similar teratogenic risk. Alitretinoin requires contraception in female patients of childbearing potential. β-Carotene in smokers. As noted, ATBC 1994 (PMID 8127329) and CARET 1996 (PMID 8602180) both found high-dose β-carotene supplementation (20-30 mg/day) increased lung cancer incidence and total mortality in current and former smokers and asbestos-exposed workers. β-Carotene supplementation is contraindicated in current smokers, recent former smokers, and those with significant asbestos exposure. Food-source β-carotene does not carry this risk. Bone and fracture risk. Chronic preformed vitamin A intake above 3,000 μg/day (10,000 IU) has been associated with elevated hip fracture risk in postmenopausal women (Feskanich 2002 JAMA) and older men (Michaelsson 2003). Proposed mechanisms involve retinoic acid-driven osteoclast activation and disruption of [vitamin D3](/compound/vitamin-d3)-mediated calcium homeostasis via RXR competition. Observational data, so causation debated — but the plausible mechanism argues for restraint in chronic supraphysiologic dosing. Hepatotoxicity. Retinol is stored in hepatic stellate cells; very high chronic intake activates stellate cells and promotes hepatic fibrosis (Sato and Lieber 1981, early rodent data extended to humans). Clinical chronic hypervitaminosis A hepatotoxicity is rare but reported with chronic intake >25,000 IU/day for years. Monitor liver enzymes in patients taking supplementation above this level. Oral isotretinoin adverse effects. Beyond teratogenicity: xerosis, cheilitis, dry eyes (with potential contact lens intolerance), epistaxis, retinoid dermatitis, myalgia and arthralgia, elevated serum triglycerides (30-50% of patients, typically mild), elevated transaminases (10-15%, usually mild, occasionally requiring dose reduction or discontinuation), hyperostosis with chronic dosing (rare outside of acitretin long-term), night vision disturbance (sometimes persistent), photosensitivity, hair thinning, and — debated — depression and suicidality. The depression association has been extensively studied; meta-analyses (Huang 2017 and others) do not find increased depression risk in treated populations vs. comparable acne severity controls, but clinicians and families should be attentive. Inflammatory bowel disease association is controversial; modern pharmacoepidemiology (Alhusayen 2013) does not support causation. Oral ATRA adverse effects in APL treatment. Differentiation syndrome ("retinoic acid syndrome"): fever, dyspnea, weight gain, pulmonary infiltrates, pericardial and pleural effusions, hypotension, and acute renal failure; occurs in 15-25% of ATRA-treated APL patients, particularly in the first 1-3 weeks; managed with dexamethasone 10 mg IV twice daily with continuation of ATRA. Pseudotumor cerebri with headache and papilledema, especially in children. Hypertriglyceridemia. Xerosis and cheilitis. Topical tretinoin adverse effects. Local irritation, erythema, dryness, peeling — dose- and formulation-dependent; usually tolerable with a gradual initiation schedule and moisturizer pairing. Photosensitivity with increased sunburn risk and increased post-inflammatory hyperpigmentation in darker skin types; sun protection (SPF 30+) is mandatory. Pregnancy category C for topical tretinoin; theoretical teratogenic risk is low with limited systemic absorption but avoidance is recommended during pregnancy and lactation. Drug and nutrient interactions. Retinoids (oral isotretinoin, acitretin, bexarotene) and tetracyclines should not be combined due to increased risk of pseudotumor cerebri. Retinoids and high-dose [vitamin A](/compound/vitamin-a) preformed supplementation should not be combined due to additive toxicity. Oral contraceptives are not a reliable sole method of contraception with retinoid therapy; dual contraception (2 methods, with abstinence and barrier methods) is required per iPLEDGE. Warfarin INR may be affected by high-dose vitamin A; monitor. Statins and retinoids both can elevate transaminases; monitor additively. Alcohol potentiates hepatic retinol storage and toxicity; avoid chronic heavy alcohol with vitamin A supplementation. Pediatric considerations. WHO supplementation protocols for children 6-59 months in high-deficiency regions (100,000-200,000 IU every 4-6 months) are safe when implemented per guideline. In non-deficient populations, routine high-dose supplementation is not indicated. Pediatric ranges for preformed vitamin A: infants 0-6 months 400 μg RAE, 7-12 months 500 μg, 1-3 years 300 μg, 4-8 years 400 μg, 9-13 years 600 μg. Upper intake levels are correspondingly lower: 600 μg (0-3 years), 900 μg (4-8 years), 1,700 μg (9-13 years), 2,800 μg (14-18 years), 3,000 μg (adults). Elderly considerations. Absorption efficiency is relatively preserved with age. The fracture risk signal at >3,000 μg/day is most concerning in older adults and postmenopausal women. Avoid stand-alone vitamin A supplementation in this population unless treating documented deficiency. Renal and hepatic impairment. No specific dose adjustment for mild-to-moderate renal impairment. In severe hepatic impairment, retinol mobilization and metabolism are disrupted; endogenous retinol levels may be low from reduced RBP synthesis even as stellate cell stores remain, making interpretation of status complex. Manage with hepatology guidance. Cancer screening consideration. High-dose β-carotene supplementation in smokers is contraindicated as noted. In patients on oral retinoid therapy for CTCL or other cancer indications, drug-specific monitoring per oncology protocol applies. Skin cancer surveillance is appropriate given systemic retinoid effects on keratinocyte biology. Overall: vitamin A is among the vitamins where dose and form truly matter. The healthy adult eating a varied whole-food diet almost never requires supplementation, and high-dose preformed vitamin A supplementation carries real risk. When replacement is needed, follow established clinical guidelines rather than megadose empiricism.
Where can I buy Vitamin A?
Visit our vendor directory to find trusted sources for Vitamin A.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
